Christine Gebski - Feb 29, 2024 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
SVP, Filtration & Chromatography
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Feb 29, 2024
Transactions value $
-$174,569
Form type
4
Date filed
3/4/2024, 09:45 PM
Previous filing
Nov 13, 2023
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Award $0 +391 +1.36% $0.00 29.2K Feb 29, 2024 Direct F1
transaction RGEN Common Stock Tax liability -$85.7K -447 -1.53% $191.79 28.7K Mar 1, 2024 Direct F2
transaction RGEN Common Stock Tax liability -$88.8K -461 -1.6% $192.71 28.3K Mar 4, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 391 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 24, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
F2 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Remarks:

SVP, Filtration & Chromatography